Takemi Yoshida

4.1k total citations
156 papers, 3.5k citations indexed

About

Takemi Yoshida is a scholar working on Molecular Biology, Pharmacology and Oncology. According to data from OpenAlex, Takemi Yoshida has authored 156 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 77 papers in Molecular Biology, 47 papers in Pharmacology and 24 papers in Oncology. Recurrent topics in Takemi Yoshida's work include Pharmacogenetics and Drug Metabolism (41 papers), Heme Oxygenase-1 and Carbon Monoxide (28 papers) and Drug Transport and Resistance Mechanisms (20 papers). Takemi Yoshida is often cited by papers focused on Pharmacogenetics and Drug Metabolism (41 papers), Heme Oxygenase-1 and Carbon Monoxide (28 papers) and Drug Transport and Resistance Mechanisms (20 papers). Takemi Yoshida collaborates with scholars based in Japan, United States and United Kingdom. Takemi Yoshida's co-authors include Satoshi Numazawa, Yukio Kuroiwa, Yukio Kuroiwa, Kazuyasu Nakaya, Sachiko Tanaka, Seiji Shioda, Takiko Oguro, Shigeo Nakajo, Aya Yoshida and Takashi Ashino and has published in prestigious journals such as Journal of Biological Chemistry, PLoS ONE and Biochemical Journal.

In The Last Decade

Takemi Yoshida

154 papers receiving 3.4k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Takemi Yoshida Japan 30 1.8k 627 434 321 270 156 3.5k
Siyaram Pandey Canada 42 2.1k 1.1× 766 1.2× 300 0.7× 452 1.4× 334 1.2× 97 4.5k
Hong‐Seob So South Korea 39 2.1k 1.1× 276 0.4× 513 1.2× 402 1.3× 413 1.5× 119 4.4k
Bao Ting Zhu United States 38 2.6k 1.4× 850 1.4× 836 1.9× 469 1.5× 634 2.3× 160 6.6k
Othman A. Al‐Shabanah Saudi Arabia 40 1.0k 0.5× 719 1.1× 491 1.1× 191 0.6× 212 0.8× 118 4.3k
Zahurin Mohamed Malaysia 34 1.4k 0.7× 472 0.8× 487 1.1× 415 1.3× 251 0.9× 165 4.5k
Qiusheng Zheng China 38 1.9k 1.1× 811 1.3× 255 0.6× 425 1.3× 366 1.4× 165 3.8k
Raekil Park South Korea 31 1.4k 0.8× 280 0.4× 275 0.6× 313 1.0× 271 1.0× 74 3.0k
Marı́a Luisa Ferrándiz Spain 39 1.8k 1.0× 369 0.6× 145 0.3× 609 1.9× 198 0.7× 98 3.9k
Feng‐Nien Ko Taiwan 41 1.7k 0.9× 671 1.1× 131 0.3× 720 2.2× 171 0.6× 101 4.1k
Gph Leung Hong Kong 36 1.9k 1.1× 422 0.7× 276 0.6× 516 1.6× 180 0.7× 158 4.4k

Countries citing papers authored by Takemi Yoshida

Since Specialization
Citations

This map shows the geographic impact of Takemi Yoshida's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Takemi Yoshida with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Takemi Yoshida more than expected).

Fields of papers citing papers by Takemi Yoshida

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Takemi Yoshida. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Takemi Yoshida. The network helps show where Takemi Yoshida may publish in the future.

Co-authorship network of co-authors of Takemi Yoshida

This figure shows the co-authorship network connecting the top 25 collaborators of Takemi Yoshida. A scholar is included among the top collaborators of Takemi Yoshida based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Takemi Yoshida. Takemi Yoshida is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kojima, Misaki, Takashi Ashino, Takemi Yoshida, et al.. (2008). IL-1 regulates the Cyp7a1 gene and serum total cholesterol level at steady state in mice. Biochemical and Biophysical Research Communications. 379(2). 239–242. 15 indexed citations
2.
3.
Kageyama, Haruaki, Fumiko Takenoya, Yasunori Hori, Takemi Yoshida, & Seiji Shioda. (2007). Morphological interaction between galanin-like peptide- and dopamine-containing neurons in the rat arcuate nucleus. Regulatory Peptides. 145(1-3). 165–168. 7 indexed citations
4.
Tanaka, Sachiko, et al.. (2006). Lipopolysaccharide-induced microglial activation induces learning and memory deficits without neuronal cell deathin rats. Journal of Neuroscience Research. 83(4). 557–566. 192 indexed citations
5.
Ashino, Takashi, et al.. (2006). Effect of interleukin-6 neutralization on CYP3A11 and metallothionein-1/2 expressions in arthritic mouse liver. European Journal of Pharmacology. 558(1-3). 199–207. 27 indexed citations
6.
Nishimaki‐Mogami, Tomoko, Yosuke Kawahara, Norimasa Tamehiro, et al.. (2005). 5α-Bile alcohols function as farnesoid X receptor antagonists. Biochemical and Biophysical Research Communications. 339(1). 386–391. 16 indexed citations
7.
Tanaka, Satoru, et al.. (2005). TISSUE- AND DOSE-DEPENDENT ALTERATION OF STRESS-INDUCIBLE PROTEINS BY β2-ADRENOCEPTOR AGONIST, SALBUTAMOL, IN RATS. The Journal of Toxicological Sciences. 30(4). 305–314. 7 indexed citations
8.
Oguro, Takiko, Yuko Takahashi, Takashi Ashino, et al.. (2002). Involvement of tumor necrosis factor α, rather than interleukin‐1α/β or nitric oxides in the heme oxygenase‐1 gene expression by lipopolysaccharide in the mouse liver. FEBS Letters. 516(1-3). 63–66. 33 indexed citations
9.
Manabe, Atsufumi, Satoshi Numazawa, Kazuo Itoh, et al.. (2000). Detection of Bisphenol-A in Dental Materials by Gas Chromatography-Mass Spectrometry.. Dental Materials Journal. 19(1). 75–86. 28 indexed citations
10.
Manabe, Atsufumi, et al.. (1996). Evaluation of Skin Irritation and Sensitization of Two Diol Solutions used as Experimental Dentin Primers in Humans and Guinea Pigs. Dental Materials Journal. 15(2). 226–232,255. 5 indexed citations
11.
Yasuda, Masako, et al.. (1996). Bufalin inhibits endothelial cell proliferation and angiogenesis in vitro. Life Sciences. 60(2). 127–134. 45 indexed citations
12.
Yoshida, Takemi, et al.. (1996). Forensic immunochemistry. Forensic Science International. 80(1-2). 163–173. 4 indexed citations
13.
Sato, Yoichi, et al.. (1996). Inhibition of Insulin-Induced Chondrogenic Differentiation of Embryonic Carcinoma Cells by a Teratogenic Compound YM9429. Biochemical and Biophysical Research Communications. 225(2). 593–599. 1 indexed citations
14.
Zhang, Lisha, Takemi Yoshida, & Yukio Kuroiwa. (1992). Stimulation of melanin synthesis of B16-F10 mouse melanoma cells by bufalin. Life Sciences. 51(1). 17–24. 24 indexed citations
15.
Oguro, Takiko, Satoshi Numazawa, Takemi Yoshida, & Yukio Kuroiwa. (1989). Induction of ornithine decarboxylase and s-adenosylmethionine decarboxylase by sulfobromophthalein in rats. Life Sciences. 45(11). 963–970. 5 indexed citations
16.
Numazawa, Satoshi, Takiko Oguro, Takemi Yoshida, & Yukio Kuroiwa. (1989). Synergistic induction of rat hepatic ornithine decarboxylase by multiple doses of cobalt chloride. Chemico-Biological Interactions. 72(3). 257–267. 2 indexed citations
17.
Yoshida, Takemi, Takiko Oguro, Satoshi Numazawa, & Yukio Kuroiwa. (1988). Effect of diethyl maleate on hepatic ornithine decarboxylase. Toxicology and Applied Pharmacology. 92(2). 194–202. 18 indexed citations
18.
Tanaka, Einosuke, et al.. (1987). Induction of cytochrome p-450 and related drug-oxidizing activities in muscone (3-methylcyclopentadecanone)-treated rats. Biochemical Pharmacology. 36(24). 4263–4267. 14 indexed citations
19.
Yoshida, Takemi, Takiko Oguro, & Yukio Kuroiwa. (1987). Hepatic and extrahepatic metabolism of deprenyl, a selective monoamine oxidase (MAO) B inhibitor, of amphetamines in rats: sex and strain differences. Xenobiotica. 17(8). 957–963. 27 indexed citations
20.
Yoshida, Takemi & Robert A. Neal. (1978). Effect of ethylenebisdiisothiocyanato sulfide (EBIS) on mouse liver δ-aminolevulinic acid synthetase. Toxicology and Applied Pharmacology. 46(2). 339–352. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Siyaram Pandey Breakdown of academic impact, for papers by Hong‐Seob So Breakdown of academic impact, for papers by Bao Ting Zhu Breakdown of academic impact, for papers by Othman A. Al‐Shabanah Breakdown of academic impact, for papers by Zahurin Mohamed Breakdown of academic impact, for papers by Qiusheng Zheng Breakdown of academic impact, for papers by Raekil Park Breakdown of academic impact, for papers by Marı́a Luisa Ferrándiz Breakdown of academic impact, for papers by Feng‐Nien Ko Breakdown of academic impact, for papers by Gph Leung
Rankless by CCL
2026